Nordic Nanovector ASA (DE:8NN) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Thor Medical has secured a three-year agreement to supply the globally leading pharmaceutical company with Pb-212 alpha-emitters for pre-clinical cancer treatment studies, highlighting its growing presence in the radiopharmaceutical industry. The supply will commence in 2025 from its new Herøya pilot facilities, further strengthening its strategic partnerships and market trust.
For further insights into DE:8NN stock, check out TipRanks’ Stock Analysis page.
